Catalyst Wire Dossier Catalyst Wire Dossier

Repatha (alirocumab)

alirocumab · Regeneron/Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Repatha (alirocumab), covering 2015-11-06 to 2015-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH) [Phase 3]

See pricing